Loading...
 
Mediterr J Rheumatol 2018;29(2):103-5
Five-year prospective multi-center cohort study of patients with giant cell arteritis in Greece
Authors Information

1: Joint Rheumatology Program, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
2: Clinical Immunology-Rheumatology Unit, 2nd Department of Medicine and Laboratory, Hippokration General Hospital, Athens, Greece
3: Rheumatology Unit, Sismanoglio Hospital, Athens, Greece
4: 4th Department of Medicine, Attikon Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
5: First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens School of Medicine, Athens, Greece
6: Private practice, Thessaloniki, Greece
7: Rheumatology Clinic, University of Ioannina, Ioannina, Greece

References
  1. Buttgereit F, Dejaco C, Matteson E L, Dasgupta B. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review. JAMA 2016;315:2442-58.
  2. Gonzalez-Gay M A, Vazquez-Rodriguez T R, Lopez-Diaz M J, Miranda-Filloy J A, Gonzalez-Juanatey C, Martin J, et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 2009;61:1454-61.
  3. Andrianakos A, Trontzas P, Christoyannis F, Dantis P, Voudouris C, Georgountzos A, et al. Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG Study. J Rheumatol 2003;30:1589-601.
  4. Labarca C, Koster M J, Crowson C S, Makol A, Ytterberg S R, Matteson E L, et al. Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study. Rheumatology (Oxford) 2016;55:347-56.
  5. Alba M A, Garcia-Martinez A, Prieto-Gonzalez S, Tavera-Bahillo I, Corbera-Bellalta M, Planas-Rigol E, et al. Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients. Medicine (Baltimore) 2014;93:194-201.
  6. Wilson J C, Sarsour K, Collinson N, Tuckwell K, Musselman D, Klearman M et al. Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis. Semin Arthritis Rheum 2017;46:819-27.
  7. Schmidt J, Smail A, Roche B, Gay P, Salle V, Pellet H, et al. Incidence of Severe Infections and Infection-Related Mortality During the Course of Giant Cell Arteritis: A Multicenter, Prospective, Double-Cohort Study. Arthritis Rheumatol 2016;68:1477-82.